JohnWesleyMcConnellMD

Pulmonology • Louisville, KY

Critical Care Medicine, Interventional Pulmonology

KPA

Request Appointment

Overview of Dr. McConnell

Dr. John McConnell is a pulmonologist in Louisville, KY and is affiliated with multiple hospitals in the area, including UofL Health - Jewish Hospital, Norton Hospital, and Norton Clark Hospital. He received his medical degree from Medical College of Georgia and has been in practice 34 years. He is one of 33 doctors at UofL Health - Jewish Hospital and one of 28 doctors at Norton Hospital who specialize in Pulmonology. He has more than 10 publications and over 450 citings.

Office
100 W Market St
Ste 2
Louisville, KY 40202
Book by Phone+1(423) 201-4394

Fax+1 502-583-8001

Education & Training

University of Kentucky College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
University of Kentucky College of MedicineResidency, Internal Medicine, 1982 - 1985
Medical College of Georgia at Augusta UniversityClass of 1982

Certifications & Licensure

IN State Medical License 1989 - 2025
KY State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Top MD Consumers Checkbook
CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013

Clinical Trials

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Terminated
Phase 2
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension Start of enrollment: 2014 Aug 20
Completed
Phase 2
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction Start of enrollment: 2014 Jul 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studies.
Marius M Hoeper, Stephan Rosenkranz, David B Badesch, Marc Humbert, David Langleben
Respiratory Medicine. 2025-01-01
Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension.
John McConnell, S Pinar Bilir, Yifan Xu, Yuen Tsang, Sumeet Panjabi
Journal of Medical Economics. 2023-10-31
1 citations
Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Associa...
Megan Mayer, David B Badesch, Kelly H Nielsen, Steven Kawut, Todd Bull
Pulmonary Circulation. 2023-04-01

Press Mentions

Lauren Gerlach, M.P.PMay 28th, 2020